AZN - Wutah dodolan YoY (TTM) AstraZeneca PLC

This LTM sales volume growth chart illustrates the impact of geopolitical tensions on logistics and testing, while the 7.50 value captures the metric level. AstraZeneca PLC (AZN) maintains stability through diversification across cardiology and oncology. High margins are driven by exclusive patents for targeted therapy, granting the behemoth significant pricing power within the rare disease segment.
astrazeneca.com (AZN) - rincian metrik lan laporan keuangan

This indicator measures real business expansion dynamics by comparing revenue over the last twelve months with the same period last year to neutralize seasonality and market noise. By analyzing the year-over-year sales trajectory (TTM), investors assess the effectiveness of the AstraZeneca PLC (AZN) R&D pipeline and the ability of its patented oncology blockbusters to generate a sustainable cash flow amid stringent regulatory conditions.